A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans.
Phase of Trial: Phase I
Latest Information Update: 03 Nov 2010
At a glance
- Drugs ABT-614 (Primary)
- Indications Brain disorders; Drug abuse
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 09 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Aug 2009 New trial record